FSA Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$67K Hold
1,485
0.02% 134
2025
Q2
$68.7K Hold
1,485
0.03% 124
2025
Q1
$90.6K Sell
1,485
-330
-18% -$19.2K 0.04% 91
2024
Q4
$103K Hold
1,815
0.04% 86
2024
Q3
$93.9K Buy
+1,815
New +$85.1K 0.04% 98
2024
Q1
$112K Sell
2,070
-107
-5% -$5.45K 0.05% 81
2023
Q4
$112K Buy
+2,177
New +$114K 0.05% 76
2021
Q1
Sell
-2,109
Closed -$131K 75
2020
Q4
$131K Buy
+2,109
New +$130K 0.07% 71
2020
Q3
Sell
-2,109
Closed -$124K 99
2020
Q2
$124K Hold
2,109
0.08% 72
2020
Q1
$118K Hold
2,109
0.1% 69
2019
Q4
$135K Buy
+2,109
New +$121K 0.1% 75

Other funds holding BMY

FSA Wealth Management's BMY Position: Q3 2025 in Review

FSA Wealth Management held its Bristol-Myers Squibb (BMY) position steady in Q3 2025 at 1,485 shares worth $67K. The position accounts for 0.02% of the portfolio, ranked #134.

FSA Wealth Management first reported a position in BMY in Q4 2019 and has held it in 11 quarters since. The position peaked at $135K in Q4 2019. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • FSA Wealth Management held 1,485 shares of Bristol-Myers Squibb worth $67K as of Q3 2025.
  • FSA Wealth Management left its Bristol-Myers Squibb share count unchanged in Q3 2025.
  • Bristol-Myers Squibb made up 0.02% of FSA Wealth Management's portfolio in Q3 2025, its #134 holding.
  • FSA Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 11 quarters since.
  • FSA Wealth Management's Bristol-Myers Squibb position peaked at $135K in Q4 2019.
  • 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.